Nuvation Bio(NUVB.US)

Last Updated 19:00:00 ET
longbridge loading

Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer | NUVB Stock News

StockTitan·
US
TMO
-0.98%
US
NUVB
+2.12%
US
IXJ
+0.25%
StockTitan·
US
TMO
-0.98%
US
NUVB
+2.12%
US
IXJ
+0.25%

Nuvation Bio to Participate in Upcoming Investor Conferences

Unusual Whales·
US
NUVB
+2.12%
US
BIB
+3.43%
US
PBE
+0.89%
Unusual Whales·
US
NUVB
+2.12%
US
BIB
+3.43%
US
PBE
+0.89%

Nuvation Bio shares are trading higher after the company reported in-line Q1 EPS results and better-than-expected sales results.

benzinga_article·
US
NUVB
+2.12%
US
XLV
-0.25%
US
FBT
+1.22%
benzinga_article·
US
NUVB
+2.12%
US
XLV
-0.25%
US
FBT
+1.22%

Wedbush Keeps Their Buy Rating on Nuvation Bio (NUVB)

Tip Ranks·
US
NUVB
+2.12%
US
PBE
+0.89%
US
SBIO
+2.81%
Tip Ranks·
US
NUVB
+2.12%
US
PBE
+0.89%
US
SBIO
+2.81%

Nuvation Bio | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 83.23 M

Earnings Watch·
US
NUVB
+2.12%
Earnings Watch·
US
NUVB
+2.12%
© 2026 Longbridge｜Disclaimer